Decreasing the TG /HDL-c and apoB/ apoA-I in our study means that the small dense LDLs are decreased significantly and coronary artery disease and myocardial infarction risk in BRFE group is much lower than control one. This evidence concerns the gene APOA1 and myocardial infarction.